JOHN LOTT

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family FLINT, MI NPI 1710691423

General Payments — all program years on this page

$388.71

  • Category: General Payments
  • Program years: PY2024
  • Record count: 20
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $388.71 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $388.7120

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $187.7010
Alkermes, Inc. $51.473
Neurocrine BioSciences, Inc. $29.721
Axsome Therapeutics, Inc. $27.041
Merck Sharp & Dohme Corporation $22.301
Novo Nordisk AS $21.041
SCPHARMACEUTICALS INC. $18.661
ITI, Inc. $17.281
PFIZER INC. $13.501

By program year

Program yearAmountRecords
2024 $388.7120

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100478036 Novo Nordisk Inc $21.04 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107557210 ABBVIE INC. $5.46 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107557212 ABBVIE INC. $24.51 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107557214 ABBVIE INC. $23.91 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107557216 ABBVIE INC. $80.69 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107557218 ABBVIE INC. $7.40 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107557220 ABBVIE INC. $7.35 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107557222 ABBVIE INC. $11.68 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107557224 ABBVIE INC. $6.97 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107557226 ABBVIE INC. $12.92 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107557228 ABBVIE INC. $6.81 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120544000 Alkermes, Inc. $17.29 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120544002 Alkermes, Inc. $16.63 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120544004 Alkermes, Inc. $17.55 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132130310 PFIZER INC. $13.50 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132277273 SCPHARMACEUTICALS INC. $18.66 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141682839 Merck Sharp & Dohme LLC $22.30 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143536085 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.28 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148371091 Axsome Therapeutics, Inc. $27.04 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150940206 Neurocrine Biosciences, Inc. $29.72 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.